Abstract
Polyspecificity (polyreactivity) is currently considered an intrinsic property of a subset of antibodies, primarily of naturally occurring autoantibodies. Polyspecificity is no longer viewed as a biologically irrelevant stickiness. Furthermore, the capacity to bind defined sets of unrelated antigens finds its structural explanation. What is most intriguing, the elucidation of the role of polyspecificity may promote a better understanding of specific recognition as a function of the entire immune system. The early events of immune recognition depend on polyspecific binding. Thus, the completeness of the naïve repertoires of antigen receptors is ensured. The process of immunologically-relevant antigen recognition that is initiated goes beyond simple molecular interaction with the antigenic determinants. It involves cellular cooperation and culminates in antibody response maturation. Recent findings also pave the way for the clinical application of posttranslationally induced polyspecificity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Landsteiner K. The Specificity of Serological Reactions. Harvard: Harvard University Press, 1947.
Dighiero G, Guilbert B, Avrameas S. Naturally occurring antibodies against nine common antigens in humans sera. II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies. J Immunol 1982; 128:2788–92. PMID:6804567
Avrameas S. Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton.’. Immunol Today 1991; 12:154–9. PMID:1715166
Casali P, Notkins AL. Probing the human B-cell repertoire with EBV: Polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol 1989; 7:513–35. PMID:2469441 doi:10.1146/annurev. iy.07.040189.002501
Quan CP, Berneman A, Pires R et al. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 1997; 65:3997–4004. PMID:9316998
Mihaylova NM, Dimitrov JD, Djoumerska-Alexieva IK et al. Inflammation-induced enhancement of IgG immunoreactivity. Inflamm Res 2008; 57(1):1–3. PMID:18209958 doi:10.1007/sOOO11-007-6213-4
van Regenmortel MH. Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationships in immunology. Vaccine 1999; 18:216–21. PMID:10506645 doi:10.1016/S0264-410X(99)00192-9
James LC, Tawfik DS. The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness. Protein Sci 2003; 12:2183–93. PMID:14500876 doi:10.1110/ps.03172703
Ditzel HJ, Itoh K, Burton DR. Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection. J Immunol 1996; 157:739–49. PMID:8752924
Crouzier R, Martin T, Pasquali JL. Heavy chain variable region, light chain variable region and heavy chain CDR3 influences on the mono-and polyreactivity and on the affinity of human monoclonal rheumatoid factors. J Immunol 1995; 154:4526–35. PMID:7722307
Ichiyoshi Y, Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med 1994; 180:885–95. PMID:8064239 doi:10.1084/jem.180.3.885
Martin T, Crouzier R, Weber JC et al. Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J Immunol 1994; 152:5988–96. PMID:8207223
Polymenis M, Stollar BD. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity. J Immunol 1994; 152(ll):5318–29. PMID:8189049
Notkins AL. Polyreactivity of antibody molecules. Trends Immunol 2004; 25:174–9. PMID:15039043 doi:10.1016/j.it.2004.02.004
Mariuzza RA. Multiple paths to multispecificity. Immunity 2006; 24:359–61. PMID:16618592 doi:10.1016/j. immuni.2006.03.009
Manivel V, Bayiroglu F, Siddiqui Z et al. The primary antibody repertoire represents a linked network of degenerate antigen specificities. J Immunol 2002; 169:888–97. PMID:12097393
Wedemayer GJ, Patten PA, Wang LH et al. Structural insights into the evolution of an antibody combining site. Science 1997; 276:1665–9. PMID:9180069 doi:10.1126/science.276.5319.1665
Yin J, Beuscher AE, Andryski SE et al. Structural plasticity and the evolution of antibody affinity and specificity. J Mol Biol 2003; 330:651–6. PMID:12850137 doi:10.1016/S0022-2836(03)00631-4
Zimmermann J, Romesberg FE, Brooks CL 3rd et al. Molecular description of flexibility in an antibody combining site. J Phys Chem B 2010; 114:7359–70. PMID:20455589 doi:10.1021/jp906421v
Yang PL, Schultz PG. Mutational analysis of the affinity maturation of antibody 48G7. J Mol Biol 1999; 294:1191–201. PMID:10600377 doi:10.1006/jmbi. 1999.3197
Yin J, Mundorff EC, Yang PL et al. A comparative analysis of the immunological evolution of antibody 28B4. Biochemistry 2001; 40:10764–73. PMID:11535051 doi:10.1021/bi010536c
Jimenez R, Salazar G, Yin J et al. Protein dynamics and the immunological evolution of molecular recognition. Proc Natl Acad Sci USA 2004; 101(ll):3803–8. PMID: 15001706 doi:10.1073/pnas.0305745101
James LC, Roversi P, Tawfik DS. Antibody multispecificity mediated by conformational diversity. Science 2003; 299:1362–7. PMID:12610298 doi:10.1126/science.1079731
Bosshard HR. Molecular recognition by induced fit: how fit is the concept? News Physiol Sci 2001; 16:171–3. PMID:11479367
Berger C, Weber-Bornhauser S, Eggenberger J et al. Antigen recognition by conformational selection. FEBS Lett 1999; 450(1–2):149–53. PMID: 10350075 doi:10.1016/S0014-5793(99)00458-5
Koshland DE. Application of a theory of enzyme specificity to protein synthesis. Proc Natl Acad Sci USA 1958; 44:98–104. PMID:16590179 doi:10.1073/pnas.44.2.98
Leder L, Berger C, Bornhauser S et al. Spectroscopic, calorimetric and kinetic demonstration of conformational adaptation in peptide-antibody recognition. Biochemistry 1995; 34:16509–18. PMID:8845380 doi:10.1021/bi00050a035
Margulies DH. Molecular interactions: stiff or floppy (or somewhere in between?). Immunity 2003; 19:772–4. PMID:14670294 doi:10.1016/S1074-7613(03)00331-5
Pashov AD, Plaxco J, Kaveri SV et al. Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity. J Biol Chem 2006; 281:29675–83. PMID:16899462 doi:10.1074/jbc.M604137200
Pashov A, Canziani G, Monzavi-Karbassi B et al. Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens. J Biol Chem 2005; 280:28959–65. PMID: 15955803 doi:10.1074/jbc.M502964200
Kieber-Emmons T, Murali R, Greene M. Therapeutic peptides and peptidomimetics. Curr Opin Biotechnol 1997; 8:435–41. PMID:9265722 doi:10.1016/S0958-1669(97)80065-1
Olsson L. Molecular mimicry of carbohydrate and protein structures by hybridoma antibodies. Bioessays 1987; 7:116–9. PMID:2446599 doi:10.1002/bies.950070306
Ghiara JB, Ferguson DC, Satterthwait AC et al. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site. J Mol Biol 1997; 266(1):31–9. PMID:9054968 doi:10.1006/jmbi. 1996.0768
Young AC, Valadon P, Casadevall A et al. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. J Mol Biol 1997; 274:622–34. PMID: 9417940 doi:10.1006/jmbi. 1997.1407
Murali R, Kieber-Emmons T. Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody. J Mol Recognit 1997; 10:269–76. PMID:9770651 doi:10.1002/(SICI) 1099-1352 (199711/12)10:6<269::AID-JMR370>3.0.CO;2-9
Luo P, Canziani G, Cunto-Amesty G et al. A molecular basis for functional peptide mimicry of a carbohydrate antigen. J Biol Chem 2000; 275:16146–54. PMID:10748116 doi:10.1074/jbc.M909121199
Sethi DK, Agarwal A, Manivel V et al. Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response. Immunity 2006; 24:429–38. PMID: 16618601 doi:10.1016/j.immuni.2006.02.010
Fernández C, Alarcon-Riquelme ME, Sverremark E. Polyreactive binding of antibodies generated by polyclonal B-cell activation. II. Crossreactive and monospecific antibodies can be generated from an identical Ig rearrangement by differential glycosylation. Scand J Immunol 1997; 45:240–7. PMID:9122612 doi:10.1046/j.1365-3083.1997.d01-398.x
Donadel G, Calabro A, Sigounas G et al. Human polyreactive and monoreactive antibodies: effect of glycosylation on antigen binding. Glycobiology 1994; 4:491–6. PMID:7827411 doi:10.1093/glycob/4.4.491
Casali P, Notkins AL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989; 10:364–8. PMID:2482031 doi:10.1016/0167-5699(89)90268-5
Sancho D, Mourao-Sa D, Joffre OP et al. Tumortherapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest 2008; 118:2098–110. PMID: 18497879 doi:10.1172/JCI34584
Baumgarth N, Herman OC, Jager GC et al. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271–80. PMID: 10899913 doi:10.1084/jem.192.2.271
Ochsenbein AF, Fehr T, Lutz C et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999; 286:2156–9. PMID: 10591647 doi:10.1126/science.286.5447.2156
McCoy KD, Stoel M, Stettler R et al. Polyclonal and specific antibodies mediate protective immunity against enteric helminth infection. Cell Host Microbe 2008; 4:362–73. PMID: 18854240 doi:10.1016/j. chom.2008.08.014
Zhou ZH, Tzioufas AG, Notkins AL. Properties and function of polyreactive antibodies and polyreactive antigen-binding B-cells. J Autoimmun 2007; 29:219–28. PMID: 17888628 doi:10.1016/j.jaut.2007.07.015
Mouquet H, Scheid JF, Zoller MJ et al. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 2010; 467:591–5. PMID:20882016 doi:10.1038/nature09385
Coutinho A, Avrameas S. Speculations on immunosomatics: potential diagnostic and therapeutic value of immune homeostasis concepts. Scand J Immunol 1992; 36:527–32. PMID: 1411298 doi:10.1111/j. 1365-3083.1992.tb03220.x
Ikematsu H, Kasaian MT, Schettino EW et al. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. J Immunol 1993; 151:3604–16. PMID:8376796
Cyster JG. Signaling thresholds and interclonal competition in preimmune B-cell selection. Immunol Rev 1997; 156:87–101. PMID:9176702 doi:10.1111/j.l600-065X.1997.tb00961.x
Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996; 381:751–8. PMID:8657279 doi:10.1038/381751a0
Janin J. Principles of protein-protein recognition from structure to thermodynamics. Biochimie 1995; 77:497–505. PMID:8589061 doi:10.1016/0300-9084(96)88166-1
Pauyo T, Hilinski GJ, Chiu PT et al. Genetic and fluorescence studies of affinity maturation in related antibodies. Mol Immunol 2006; 43:812–21. PMID:16137768 doi:10.1016/j.molimm.2005.07.001
Babor M, Kortemme T. Multi-constraint computational design suggests that native sequences of germline antibody H3 loops are nearly optimal for conformational flexibility. Proteins 2009; 75:846–58. PMID:19194863 doi:10.1002/prot.22293
Furukawa K, Akasako-Furukawa A, Shirai H et al. Junctional amino acids determine the maturation pathway of an antibody. Immunity 1999; 11:329–38. PMID:10514011 doi:10.1016/S1074-7613(00)80108-9
Saenko VA, Rott GM, Poverennyi AM. Latent autoantibodies to cardiolipin in the blood serum of healthy subjects. Biull Eksp Biol Med 1989; 107:217–9. PMID:2923980
Bobrovnik SA. Transformation of serum immunoglobulins and monoclonal antibodies into polyreactive immunoglobulins. Ukr Biokhim Zh 1997; 69:97–109. PMID:9606831
McMahon MJ, O’Kennedy R. Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH. J Immunol Methods 2000; 241:1–10. PMID: 10915844 doi:10.1016/S0022-1759(00)00196-4
Bouvet JP, Stahl D, Rose S et al. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents. J Autoimmun 2001; 16:163–72. PMID: 11247642 doi:10.1006/jaut.2000.0472
Dimitrov JD, Roumenina LT, Doltchinkova VR et al. Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions. J Biol Chem 2007; 282:26696–706. PMID: 17636257 doi:10.1074/jbc.M702751200
Djoumerska-Alexieva IK, Dimitrov JD, Voynova EN et al. Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis. FEBS J 2010; 277:3039–50. PMID:20546303 doi:10.1111/j.l742-4658.2010.07714.x
Fish F, Ziff M. Hidden anti-double stranded DNA antibodies in autoimmune mice. Clin Exp Immunol 1982; 49:587–97. PMID:6756722
Saenko VA, Kabakov AE, Poverenny AM. Hidden high-avidity anti-DNA antibodies occur in normal human gammaglobulin preparations. Immunol Lett 1992; 34:1–5. PMID: 1282496 doi:10.1016/0165-2478(92)90019-K
Cabiedes J, Cabrai AR, Alarcon-Segovia D. Hidden anti-phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments. Eur J Immunol 1998; 28:2108–14. PMID:9692879 doi:10.1002/(SICI) 1521-4141(199807)28:07<2108::AID-IMMU21087gt;3.0.CO;2-R
St-Amour I, Laroche A, Bazin R et al. Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins. Clin Immunol 2009; 133:52–60. PMID: 19604724 doi:10.1016/j.clim.2009.06.005
Zöller-Utz IM, Esslinger B, Schulze-Krebs A et al. Natural hidden autoantibodies to tissue transglutaminase cross-react with fibrinogen. J Clin Immunol 2010; 30:204–12. PMID:19943187 doi:10.1007/s10875-009-9347-z
Dimitrov JD, Planchais C, Kang J et al. Heterogeneous antigen recognition behavior of induced polyspecific antibodies. Biochem Biophys Res Commun 2010; 398:266–71. PMID:20599726 doi:10.1016/j. bbrc.2010.06.073
Dimitrov JD, Ivanovska ND, Lacroix-Desmazes S et al. Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J Biol Chem 2006; 281:439–46. PMID:16246843 doi:10.1074/jbc.M509190200
Dimitrov JD, Lacroix-Desmazes S, Kaveri SV et al. Transition towards antigen-binding promiscuity of a monospecific antibody. Mol Immunol 2007; 44:1854–63. PMID:17097144 doi:10.1016/j. molimm.2006.10.002
Willcox BE, Gao GF, Wyer JR et al. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 1999; 10:357–65. PMID:10204491 doi:10.1016/S1074-7613(00)80035-7
Boniface JJ, Reich Z, Lyons DS et al. Thermodynamics of T-cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning. Proc Natl Acad Sci USA 1999; 96:11446–51. PMID: 10500196 doi:10.1073/pnas.96.20.11446
Djoumerska-Alexieva IK, Dimitrov JD, Nacheva J et al. Protein destabilizing agents induce polyreactivity and enhanced immunomodulatory activity in IVIg preparations. Autoimmunity 2009; 42:365–7. PMID:19811303 doi:10.1080/08916930902832181
Dumont ME, Corin AF, Campbell GA. Noncovalent binding of heme induces a compact apocytochrome c structure. Biochemistry 1994; 33:7368–78. PMID:8003502 doi:10.1021/bi00189a043
Dimitrov JD, Vassilev TL. Cofactor-mediated protein promiscuity. Nat Biotechnol 2009; 27:892. PMID: 19816439 doi:10.1038/nbt1009-892a
Darley-Usmar V, Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions and the vascular system. Pharm Res 1996; 13:649–62. PMID:8860419 doi:10.1023/A:1016079012214
Biemond P, Swaak AJ, van Eijk HG et al. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radic Biol Med 1988; 4:185–98. PMID:2833431 doi:10.1016/0891-5849(88)90026-3
Wentworth AD, Jones LH, Wentworth P Jr. et al. Antibodies have the intrinsic capacity to destroy antigens. Proc Natl Acad Sci USA 2000; 97:10930–5. PMID: 11005865 doi:10.1073/pnas.97.20.10930
Wentworth P Jr., McDunn JE, Wentworth AD et al. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 2002; 298:2195–9. PMID: 12434011 doi:10.1126/science. 1077642
Nieva J, Wentworth P Jr. The antibody-catalyzed water oxidation pathway—a new chemical arm to immune defense? Trends Biochem Sci 2004; 29:274–8. PMID:15130564 doi:10.1016/j.tibs.2004.03.009
Wentworth P Jr., Nieva J, Takeuchi C et al. Evidence for ozone formation in human atherosclerotic arteries. Science 2003; 302:1053–6. PMID:14605372 doi:10.1126/science.1089525
Wagener FA, Volk HD, Willis D et al. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 2003; 55:551–71. PMID:12869663 doi:10.1124/pr.55.3.5
Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett 2005; 157:175–88. PMID: 15917143 doi:10.1016/j.toxlet.2005.03.004
Balla J, Vercellotti GM, Nath K et al. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant 2003; 18(Suppl 5):v8–12. PMID:12817058 doi:10.1093/ndt/gfgl034
McIntyre JA. The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation-reduction reactions. Thromb Res 2004; 114:579–87. PMID:15507294 doi:10.1016/j. thromres.2004.08.008
McIntyre JA, Wagenknecht DR, Ramsey CJ. Redox-reactive antiphospholipid antibody differences between serum from Alzheimer’s patients and age-matched controls. Autoimmunity 2009; 42:646–52. PMID:19886736 doi:10.3109/08916930903074833
Zhang M, Michael LH, Grosjean SA et al. The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 2006; 41:62–7. PMID: 16781728 doi:10.1016/j.yjmcc.2006.02.006
Zhang M, Carroll MC. Natural antibody mediated innate autoimmune response. Mol Immunol 2007; 44:103–10. PMID: 16876247 doi:10.1016/j.molimm.2006.06.022
Bobrovnik SA. Mechanisms for increasing the activity of polyreactive immunoglobulins in vivo. Ukr Biokhim Zh 1999; 71:129–35. PMID:10609340
Hansen MB, Svenson M, Diamant M et al. lnterleukin-6 autoantibodies: Possible biological and clinical significance. Leukemia 1995; 9:1113–5. PMID:7630180
Meager A. Natural autoantibodies to interferons. J Interferon Cytokine Res 1997; 17(Suppl l):S51–3. PMID:9241617
Djoumerska I, Tchorbanov A, Pashov A et al. The autoreactivity of therapeutic intravenous immunoglobulin (IVIg) preparations depends on the fractionation methods used. Scand J Immunol 2005; 61:357–63. PMID:15853919 doi:10.1111/j.1365-3083.2005.01568.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Dimitrov, J.D., Pashov, A.D., Vassilev, T.L. (2012). Antibody Polyspecificity. In: Lutz, H.U. (eds) Naturally Occurring Antibodies (NAbs). Advances in Experimental Medicine and Biology, vol 750. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3461-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3461-0_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3460-3
Online ISBN: 978-1-4614-3461-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)